Your browser doesn't support javascript.
loading
Comparison among different diagnostic criteria for chronic ocular graft-versus-host disease applied with and without pre-transplant ophthalmological examination.
Giannaccare, Giuseppe; Versura, Piera; Bonifazi, Francesca; Sessa, Mariarosaria; Campos, Emilio C.
Affiliation
  • Giannaccare G; Ophthalmology Unit, DIMES, Alma Mater Studiorum, University of Bologna, S. Orsola- Malpighi University Hospital, Bologna, Italy. giuseppe.giannaccare@gmail.com.
  • Versura P; Ophthalmology Unit, DIMES, Alma Mater Studiorum, University of Bologna, S. Orsola- Malpighi University Hospital, Bologna, Italy.
  • Bonifazi F; Haematology Institute 'L.A. Seragnoli', DIMES, Alma Mater Studiorum, University of Bologna, S. Orsola-Malpighi University Hospital, Bologna, Italy.
  • Sessa M; Haematology Institute 'L.A. Seragnoli', DIMES, Alma Mater Studiorum, University of Bologna, S. Orsola-Malpighi University Hospital, Bologna, Italy.
  • Campos EC; Ophthalmology Unit, DIMES, Alma Mater Studiorum, University of Bologna, S. Orsola- Malpighi University Hospital, Bologna, Italy.
Eye (Lond) ; 33(1): 154-160, 2019 01.
Article in En | MEDLINE | ID: mdl-30194377
ABSTRACT

PURPOSE:

To compare the proportion and the agreement rate in the diagnosis of chronic ocular graft-versus-host disease (GVHD) among three criteria applied with and without ophthalmological examination before hematopoietic stem cell transplantation (HSCT).

METHODS:

National Institutes of Health (NIH), International Consensus Criteria on ocular GVHD (ICCGVHD) and TFOS Dry Eye Workshop (DEWS) II criteria were used for the diagnosis of ocular GVHD according to two protocols ophthalmological examination after HSCT (Protocol A), or before and after HSCT (Protocol B). Proportion of GVHD diagnosis and inter-rate agreement coefficient Kappa (K) among the criteria were calculated.

RESULTS:

One hundred nine patients undergone HSCT were included. NIH, ICCGVHD and DEWS II criteria diagnosed ocular GVHD in 14.7%, 17.4% and 59.6% of the patients (Protocol A), whereas in 11.9%, 15.6% and 33.0% of the HSCT patients (Protocol B). The coefficient K for the proportion of patients diagnosed with ocular GVHD by NIH and ICCGVHD criteria was K = 0.626 (Protocol A) and K = 0.615 (Protocol B). The K coefficient by NIH and DEWS II criteria was K = 0.144 (Protocol A), and K = 0.233 (Protocol B). The K coefficient by ICCGVHD and DEWS II criteria was K = 0.250 (Protocol A) and K = 0.499 (Protocol B). The K coefficient for ocular GVHD diagnosis applying Protocol A and B was K = 0.881 if NIH criteria were used, K = 0.933 if ICCGVHD criteria were used and K = 0.501 if DEWS II criteria were used.

CONCLUSIONS:

The diagnosis of ocular GVHD varied significantly in our cohort of hematological patients according to both the diagnostic criteria used and the visit protocols applied.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Dry Eye Syndromes / Hematopoietic Stem Cell Transplantation / Conjunctiva / Diagnostic Techniques, Ophthalmological / Eyelids / Graft vs Host Disease Type of study: Diagnostic_studies / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Eye (Lond) Journal subject: OFTALMOLOGIA Year: 2019 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Dry Eye Syndromes / Hematopoietic Stem Cell Transplantation / Conjunctiva / Diagnostic Techniques, Ophthalmological / Eyelids / Graft vs Host Disease Type of study: Diagnostic_studies / Etiology_studies / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: Eye (Lond) Journal subject: OFTALMOLOGIA Year: 2019 Document type: Article Affiliation country: